News
2026
John Joyoprayitno, Sarah Mayes, PhD, and Dan Peterson, MD Named Finalists for Entrepreneur Of The Year® 2026 Gulf South Award.
2025
Alafair Biosciences President & CEO and co-founder John Joyoprayitno named to Inc’s Business Leader of the Year list. Company also earns spot on Inc’s Best in Business list.
Alafair Biosciences Announces First Clinical Use of VersaCoatTM Flowable Hydrogel in Foot & Ankle and Hand & Wrist Procedures
With 722% Revenue Growth Over Three Years, Alafair Biosciences Celebrates Its Third Appearance on
the Inc. 5000 List
Alafair Biosciences Receives 510(k) Clearance for VersaCoatTM Tendon Protector and VersaCoatTM
Nerve Protector
Alafair Biosciences Named
to Inc.’s 2025 Best
Workplaces List
Alafair Biosciences Announces First Patient Enrolled in Multi-Center Study Evaluating VersaWrap® Tendon Protector for Achilles Repair
Alafair Biosciences Ranked #2 on the 2025 Longhorn 100
List of Fastest-Growing Longhorn-Led Businesses
With 51% Year-over-Year Growth, Alafair Biosciences moves up 41 spots to No. 13 on the Inc. Regionals: Southwest List
Inc. Names Alafair Biosciences’ Sarah Mayes, Ph.D. to Its 2025 Female Founders 500 List
Alafair Biosciences Reports Strong Growth in 2024
2024
Alafair Biosciences Celebrates Over 22,000 Implants of VersaWrap® Hydrogel Sheet in Patients
Alafair Biosciences CEO
John Joyoprayitno Wins 2024 Austin Business Journal’s
Best CEO Award
Alafair Biosciences to Exhibit VersaWrap®, Recently Awarded an Innovative Technology Contract, at the Vizient® Innovative Technology Exchange
For the Second Year, Alafair Biosciences Makes Inc. 5000, With Three-Year Revenue Growth of 597%
Alafair Biosciences Awarded Synthetic Implantable Products Agreement with Premier, Inc. for VersaWrap® Hydrogel Sheet
Alafair Biosciences Receives Innovative Technology Contract from Vizient for VersaWrap®
Alafair Biosciences reports record-breaking 2023
business results
With a 2-Year Revenue Growth of 234%, Alafair Biosciences Ranks No. 54 on 2024 Inc. 5000 Regionals: Southwest’s Fastest-Growing Private Companies
2023
Alafair Biosciences
Announces 12,000+ VersaWrap® Implants
in Patients
Alafair Biosciences
Selected to Exhibit VersaWrap at Vizient Innovative Technology Exchange
Alafair recognized as
Austin’s Fast Growing
Medical Device Company
2022
Alafair Biosciences is named
a Best Place to Work by
Austin Business Journal
Alafair Biosciences
Announces VersaWrap®
Sales Milestone
Alafair Enrolls Tenth
Patient in Distal Radius
Fracture Clinical Study
Alafair Enrolls First
Patient in Hand
Tendon Clinical Study
2021
Eric Giza, MD, FACS Joins Alafair Biosciences
Scientific & Clinical
Advisory Board
Alafair Biosciences launches VersaWrap, a plant-based, non-collagen, bioresorbable interface for tendon and/or peripheral nerve
Alafair Biosciences appoints John Joyoprayitno as new President and CEO
2020
Alafair Biosciences Receives 510(k) Clearance for VersaWrap® Nerve Protector
2019
Alafair Biosciences
Announces VersaWrap®
Tendon Protector Sales Milestone
Alafair Biosciences Raises
Over $7.2 Million in
Series B/B-1 Financing
2018
Alafair Biosciences
Launches VersaWrap
Tendon Protector
2016
Alafair Biosciences Receives FDA 510(k) Clearance for VersaWrap Tendon Protector